Mereo BioPharma Group plc (MREO)
NASDAQ: MREO · Real-Time Price · USD
0.2963
-0.0096 (-3.14%)
At close: Aug 7, 2026, 4:00 PM EDT
0.3049
+0.0086 (2.90%)
After-hours: Aug 7, 2026, 7:38 PM EDT
Mereo BioPharma Group Market Cap
Mereo BioPharma Group has a market cap or net worth of $47.29 million as of August 7, 2026. Its market cap has decreased by -81.29% in one year.
Market Cap
47.29M
Enterprise Value
11.07M
1-Year Change
-81.29%
Ranking
Category
Stock Price
$0.30
ChartMarket Cap Chart
Since April 24, 2019, Mereo BioPharma Group's market cap has decreased from $124.83M to $47.29M, a decrease of -62.11%. That is a compound annual growth rate of -12.46%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 7, 2026 | 47.29M | -28.68% |
| Dec 31, 2025 | 66.31M | -87.77% |
| Dec 31, 2024 | 542.14M | 67.64% |
| Dec 29, 2023 | 323.39M | 269.38% |
| Dec 30, 2022 | 87.55M | -49.64% |
| Dec 31, 2021 | 173.85M | -28.05% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Apr 24, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Instil Bio | 50.25M |
| Veraxa Biotech AG | 50.18M |
| aTyr Pharma | 50.14M |
| Immutep | 49.76M |
| Filana Therapeutics | 48.07M |
| Karyopharm Therapeutics | 48.05M |
| Seres Therapeutics | 46.97M |
| Impact BioMedical | 46.91M |